Drug Trial Radar · NCT04324346
Central Catheters Used for Chemotherapy in Women With Breast Cancer
Last checked: Nov 19, 2026Latest source record: Mar 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
250
Actual
Start
Apr 1, 2016
Primary completion
Feb 1, 2021
Study completion Feb 1, 2021
Sponsor
- Lead sponsor
- Swedish Red Cross University CollegeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Karolinska Institutet; KTH Royal Institute of Technology; Karolinska University Hospital; Stockholm South General Hospital; Norwegian University of Science and Technology
- First posted
- Mar 27, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall aim of this study is to evaluate two different central venous lines, PICC-lines (PICC) and subcutaneous venous access ports (SVAP) used for chemotherapy in women with breast cancer. The study will compare complications, material wear of the catheters used, patients'- and health care professionals' experiences, and costs. The study will give knowledge about which central venous access that is the most advantageous regarding adjuvant chemotherapy for women with breast cancer in the aspects of safety, quality of care, and quality of life.
Conditions
- Catheter Related Complications
Interventions
FEC75 (or EC90) x 6Drug
Type of Chemotherapy
FEC100 + Taxotere (EC90 + Taxotere) 3+3Drug
Type of Chemotherapy
PaclitaxelDrug
Type of Chemotherapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- ComplicationsTime frame: Through study completion up to 18 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Onkologiska kliniken, Karolinska University Hospital, Danderyd Hospital
Stockholm, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.